Nifedipina Mylan Generics (Nifedipine)

Nifedipine, the active ingredient in Nifedipina Mylan Generics, is a calcium channel blocker presented as an oral formulation for oral use. It is employed to manage high blood pressure, relieve chest pain from angina, and improve blood flow in Raynaud's phenomenon.

GNH USA supplies Nifedipina Mylan Generics as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, and ensures reliable logistics. The company adheres to stringent quality standards and provides regulatory documentation to support safe distribution across global markets.

Nifedipine is a calcium channel blocker used to treat vascular and cardiac conditions.

- Hypertension: reduces systemic vascular resistance, leading to sustained blood pressure control in adults with primary hypertension. - Angina pectoris: dilates coronary arteries and lowers myocardial oxygen demand, providing relief from exertional chest pain. - Raynaud's phenomenon: relaxes digital arterioles, enhancing peripheral blood flow and decreasing the frequency of vasospastic attacks.

Nifedipine may cause a range of adverse reactions.

Common Side Effects: - Headache - Flushing - Peripheral edema - Dizziness

Serious or Rare Side Effects: - Severe hypotension - Myocardial infarction - Allergic reactions such as rash or angioedema

Before initiating therapy, several precautions should be considered.

- Monitor blood pressure: check regularly to avoid excessive hypotension. - Assess cardiac function: evaluate for existing heart failure or recent myocardial infarction. - Use caution in hepatic impairment: dose adjustments may be required. - Avoid abrupt discontinuation: tapering helps prevent rebound hypertension. - Review concomitant medications: consider additive effects with other antihypertensives. - Store at room temperature: keep in the original pack, protect from moisture.

Nifedipine can interact with several drug classes.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) may raise plasma levels. - Co‑administration with other antihypertensives can cause excessive blood pressure drop. - Grapefruit juice may increase nifedipine exposure.

Moderate Interactions (Monitor Closely):\n- Beta‑blockers: may blunt compensatory heart rate response. - Diuretics: additive hypotensive effect. - Digoxin: increased risk of arrhythmia when combined with significant hypotension.